COM:PHARMAENGINE
智擎生技製藥股份有限公司
- Stock
Last Close
96.20
22/11 05:30
Market Cap
13.67B
Beta: -
Volume Today
845.11K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -117.85M - | 124.32M 205.49% | 406.99M 227.37% | 837.91M 105.88% | 496.99M 40.69% | 163.77M 67.05% | 49.67M 69.67% | 752.48M 1,415.04% | 545.39M 27.52% | 392.46M 28.04% | 274.65M 30.02% | |
depreciation and amortization | 338K - | 280K 17.16% | 1.63M 483.57% | 3.00M 83.29% | 3.04M 1.67% | 2.93M 3.84% | 6.71M 129.06% | 12.56M 87.24% | 10.26M 18.28% | 8.61M 16.10% | 9.02M 4.77% | |
deferred income tax | 12.57M - | 25.11M 99.73% | 28.27M 12.57% | -29.32M 203.70% | -45.71M 55.92% | -87.57M 91.55% | 35.68M 140.75% | -37.37M 204.72% | -186.78M 399.88% | -16.76M - | ||
stock based compensation | 63.18M - | 14.10M 77.68% | 19.90M 41.17% | 61.52M 209.07% | 17.31M 71.86% | 15.25M 11.92% | 5.84M 61.70% | -1.05M 118.07% | 89K 108.44% | 2.37M 2,559.55% | 3.38M 42.80% | |
change in working capital | 10.01M - | -6.03M 160.23% | 21.55M 457.39% | 25.98M 20.55% | -766.39M 3,049.47% | 712.76M 193.00% | -14.06M 101.97% | -620.68M 4,313.88% | 576.02M 192.80% | -27.51M 104.78% | 8.76M 131.85% | |
accounts receivables | 3.65M - | -15.55M 525.50% | 538.77M 3,564.31% | 3.69M 99.31% | -13.81M 473.64% | |||||||
inventory | -10.19M - | -5.97M 41.39% | -3.40M 43.07% | -4.56M 34.31% | -623K 86.35% | 19.31M 3,199.04% | -28.94M 249.91% | 18.47M 163.83% | ||||
accounts payables | -20.08M - | 15.55M 177.45% | -538.77M 3,564.31% | -3.69M 99.31% | ||||||||
other working capital | 36.17M - | -760.42M 2,202.41% | 716.15M 194.18% | 6.93M 99.03% | -620.06M 9,050.01% | 556.71M 189.78% | 1.44M 99.74% | 4.09M 185.30% | ||||
other non cash items | -15.62M - | -26.70M 70.90% | -30.36M 13.73% | -28.70M 5.48% | -44.54M 55.19% | -61.91M 39.00% | -67.75M 9.44% | -41.16M 39.24% | -15.31M 62.80% | -173.92M 1,035.63% | -22.09M 87.30% | |
net cash provided by operating activities | -47.37M - | 131.09M 376.75% | 447.99M 241.76% | 870.38M 94.29% | -339.30M 138.98% | 745.23M 319.63% | 16.08M 97.84% | 64.77M 302.84% | 929.67M 1,335.36% | 202.01M 78.27% | 256.97M 27.20% | |
investments in property plant and equipment | -95K - | -11.80M 12,323.16% | -1.15M 90.29% | -489K 57.33% | -510K 4.29% | -208K 59.22% | -608K 192.31% | -229K 62.34% | -3.94M 1,622.27% | -958K 75.71% | ||
acquisitions net | -351K - | 110K 131.34% | 608K - | |||||||||
purchases of investments | -2.72B - | 652.05M 123.97% | -2.85B 536.72% | -3.93B 38.02% | -3.32B 15.46% | -2.13B 35.93% | -700M 67.12% | -311.84M 55.45% | -1.73B 456.28% | |||
sales maturities of investments | 2.21B - | 3.33B 50.42% | 3.30B 0.72% | 3.89B 17.84% | 595M 84.72% | 127.86M 78.51% | 880.22M 588.40% | |||||
other investing activites | -9K - | -4.36M 48,355.56% | -1.02M 76.68% | -1.16M 14.45% | 1.50M 229.12% | 1.29M 13.97% | 5K 99.61% | -679K 13,680.00% | -1.77M 160.53% | -195K 88.98% | -40K 79.49% | |
net cash used for investing activites | -9K - | -4.46M 49,411.11% | -2.73B 61,224.15% | 649.74M 123.78% | -634.27M 197.62% | -600.96M 5.25% | -18.50M 96.92% | 1.76B 9,633.80% | -107.00M 106.07% | -188.12M 75.81% | -855.48M 354.76% | |
debt repayment | -73.64M - | -660K 99.10% | -491K 25.61% | |||||||||
common stock issued | 1.14B - | 70.74M 93.79% | 7.96M 88.75% | 19.16M 140.71% | 14.15M 26.13% | 6.70M 52.64% | 11.90M 77.50% | 491K 95.87% | ||||
common stock repurchased | -73.64M - | -125.52M 70.44% | -3.84M 96.94% | -133.41M 3,372.41% | ||||||||
dividends paid | -101.94M - | -101.56M 0.38% | -245.17M 141.40% | -294.31M 20.04% | -145.67M 50.51% | -72.83M 50.00% | -363.99M 399.76% | -387.71M 6.52% | -287.19M 25.93% | |||
other financing activites | -87.25M - | -28.88M 66.90% | -61.29M 112.24% | 73.64M 220.15% | -3.03M 104.11% | -10.82M 257.10% | -9.60M 11.30% | -8.00M 16.68% | -7.54M 5.74% | |||
net cash used provided by financing activities | 1.14B - | 70.74M 93.79% | -181.24M 356.20% | -111.28M 38.60% | -292.31M 162.67% | -361.25M 23.59% | -262.98M 27.20% | -87.50M 66.73% | -507.00M 479.46% | -395.71M 21.95% | -294.73M 25.52% | |
effect of forex changes on cash | -42K - | -246K 485.71% | 123K 150% | -33K 126.83% | -173K 424.24% | 1.56M 1,002.89% | -746K 147.76% | |||||
net change in cash | 1.09B - | 197.37M 81.93% | -2.47B 1,349.36% | 1.41B 157.12% | -1.27B 189.86% | -217.02M 82.85% | -265.58M 22.38% | 1.74B 756.30% | 314.93M 81.93% | -381.81M 221.24% | -893.24M 133.95% | |
cash at beginning of period | 1.61B - | 2.70B 67.88% | 2.90B 7.31% | 432.52M 85.08% | 1.84B 325.68% | 575.36M 68.75% | 358.35M 37.72% | 92.77M 74.11% | 1.84B 1,878.79% | 2.15B 17.16% | 1.77B 17.75% | |
cash at end of period | 2.70B - | 2.90B 7.31% | 432.52M 85.08% | 1.84B 325.68% | 575.36M 68.75% | 358.35M 37.72% | 92.77M 74.11% | 1.84B 1,878.79% | 2.15B 17.16% | 1.77B 17.75% | 875.62M 50.50% | |
operating cash flow | -47.37M - | 131.09M 376.75% | 447.99M 241.76% | 870.38M 94.29% | -339.30M 138.98% | 745.23M 319.63% | 16.08M 97.84% | 64.77M 302.84% | 929.67M 1,335.36% | 202.01M 78.27% | 256.97M 27.20% | |
capital expenditure | -95K - | -11.80M 12,323.16% | -1.15M 90.29% | -489K 57.33% | -510K 4.29% | -208K 59.22% | -608K 192.31% | -229K 62.34% | -3.94M 1,622.27% | -958K 75.71% | ||
free cash flow | -47.37M - | 130.99M 376.54% | 436.19M 232.99% | 869.24M 99.28% | -339.79M 139.09% | 744.72M 319.17% | 15.87M 97.87% | 64.16M 304.29% | 929.44M 1,348.61% | 198.07M 78.69% | 256.01M 29.25% |
All numbers in (except ratios and percentages)